Harvard T.H. Chan School of Public Health and STAT will jointly present a free, live ForumHSPH.org webcast, The 21st Century Cures Act: Implications for Research and Drug Development, Monday, February 27, 2017, 12:30-1:30pm ET. The passage of the 21st Century Cures Act has drawn both applause and criticism. A sweeping bipartisan effort with multiple components, the law dramatically boosts funding for medical research, particularly in areas such as cancer and brain disease. The law also relaxes regulatory processes for pharmaceuticals and medical devices. In doing so, the law’s supporters point to the potential for faster treatments benefiting from a streamlined approval process. Critics raise concerns that safety and efficacy might be compromised, with potentially devastating consequences. And the law also has been questioned for failing to explicitly address high drug prices, a growing public issue. These debates are unfolding as the Trump administration is expected to imminently announce its choice for a new FDA commissioner, who will head an agency directly impacted by the Cures act. In this Forum, experts will explore the implications of the law for biomedicine, regulation, pharmaceuticals and patient advocacy. Expert participants will include Dr. Otis Brawley, Chief Medical Officer, American Cancer Society; Ms. Pamela Tenaerts, Executive Director of the Clinical Trials Transformation Initiative; Dr. Jeffrey Drazen, Editor-in-Chief, The New England Journal of Medicine; Dr. Aaron Kesselheim, Associate Professor of Medicine, Harvard Medical School/Brigham and Women’s Hospital, and Director of the Program On Regulation, Therapeutics, And Law. Moderator will be Mr. Ed Silverman, Senior Writer, STAT. Watch the webcast at ForumHSPH.org. E-mail questions for the expert participants any time before or during the live webcast to email@example.com. Or Tweet them to @ForumHSPH using #CuresAct. We’ll also be conducting a live chat on The Forum’s The 21st Century Cures Act web page. If time does not allow for us to ask your question, we encourage you to continue the conversation by posting comments on our website at ForumHSPH.org.